Denekamp, Netherlands

Gerrit Jan Bouke Ettema


 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Denekamp, NL (2001)
  • Nÿmegen, NL (2004)

Company Filing History:


Years Active: 2001-2004

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gerrit Jan Bouke Ettema: Innovator in Pharmaceutical Chemistry

Introduction

Gerrit Jan Bouke Ettema is a notable inventor based in Denekamp, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug synthesis. With a total of 3 patents to his name, Ettema's work has had a meaningful impact on the industry.

Latest Patents

Ettema's latest patents include a process for making bicalutamide and its intermediates. This innovative method utilizes p-fluorobenzenesulfinic acid salt as a reagent, showcasing his expertise in chemical synthesis. Another significant patent involves imidazopyridine derivatives, where he developed a process to produce these compounds with high purity, exceeding 95%. This achievement highlights his commitment to advancing pharmaceutical manufacturing techniques.

Career Highlights

Ettema is currently associated with Synthon B.V., a company known for its focus on developing complex pharmaceuticals. His role at Synthon has allowed him to further his research and contribute to the company's mission of providing high-quality medicines. His work has not only advanced the field but has also positioned him as a key player in pharmaceutical innovation.

Collaborations

Ettema has collaborated with several esteemed colleagues, including Jacobus Maria Lemmens and Theodorus Hendricus Antonius Peters. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Gerrit Jan Bouke Ettema's contributions to pharmaceutical chemistry through his innovative patents and collaborative efforts underscore his importance in the field. His work continues to influence the development of new medications and processes, making a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…